8 April 2023

RNZ's Kim Hill speaks to a participant in our CAR T-cell clinical trial, poet Michele Leggott.
Michele Leggott's latest book of poetry, Face to the Sky, explores her encounter with 19th-century New Zealand botanical artist Emily Cumming Harris.
But there's more to this story - Michele was battling non-Hodgkin's lymphoma while working on the book.
In early 2020, Michele received her diagnosis, just as the Covid-19 lockdowns began. Chemotherapy, radiotherapy, and a stem cell transplant in 2021 failed to cure her cancer. Finally, in early 2022, Michele was able to participate in a CAR T-cell therapy trial at the Malaghan Institute in Wellington.
"This is the future ... The Malaghan trial, the goal of that is to get publicly funded CAR T in this country so that you don't have to be on a trial to get it. If that can happen, it'll bring down hospital costs, you'll save lives."
Related articles

Funding boost to improve lung cancer treatment outcomes in Aotearoa New Zealand
5 September 2025

Cancer, measles and allergic disease research funded in latest HRC grants round
19 August 2025

Malaghan cancer research double finalists in KiwiNet Research Commercialisation awards
7 August 2025

Horizontal mitochondria transfer: 10 years on from a groundbreaking discovery
7 May 2025

Kjesten Wiig: bringing life-changing treatments to life
27 February 2025

Malaghan CAR T-cell cancer therapy trial expands to Christchurch and Auckland
13 February 2025